Partyka et al. and Karabon et al. found that the variation on BTLA rs1982809 G>A gene polymorphism might be a potential risk factor for the development of chronic lymphocytic leukemia (CLL) and renal cell carcinoma [16, 17]. Here, BTLA is linked to B-cell chronic lymphocytic leukemia.